ARTICLE | Company News
NICE backs Humira, Acomplia
June 26, 2008 1:01 AM UTC
The U.K.'s NICE recommended Humira adalimumab from Abbott (NYSE:ABT) to treat plaque psoriasis and Acomplia rimonabant from sanofi-aventis (Euronext:SAN; NYSE:SNY) to treat obese and overweight adults...